Document is current
Any future updates will be listed below
-
Authors
Nishioka, Yuichi https://orcid.org/0000-0002-1956-3925
Hayashino, Yasuaki
Kurosawa, Kentaro
Takano, Kiyoko
Matsunaga, Satoshi
Okamura, Shintaro
Tsujii, Satoru
Ishii, Hitoshi
,
-
Funding
Funding for this research was provided by:
the Japan Society for the Promotion of Science (22H03355, 23K24613, 24K22341)
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 9 May 2025
First Online: 10 June 2025
Declarations
:
: Yuichi Nishioka received consultation fees from Novo Nordisk and speaker fees from Sanofi, Daiichi Sankyo, and DeSC Healthcare. Hitoshi Ishii received speaker fees from Eli Lilly Japan K.K., Merck & Co., Inc., Sanofi K.K, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Japan, and Sumitomo Pharma. Yasuaki Hayashino, Kentaro Kurosawa, Kiyoko Takano, Satoshi Matsunaga, Shintaro Okamura, and Satoru Tsujii have nothing to disclose.
: This study was approved by the Ethics Committee of Tenri Hospital. The authors confirm they had permissions to access and use the registry data (from the owners of the registry) for this study.
